Lila Biologics, Inc. — Form D
Lila Biologics, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2023-09-28. The offering totals $10.6M, of which $9.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-09-28
- Form: D
- Accession: 0001993436-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.6M
- Amount sold: $9.5M
- Remaining: $1.0M
- Investors: 18
- Date of first sale: 2023-09-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-493247
Issuer
- Name: Lila Biologics, Inc.
- CIK: 0001993436
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 1616 Eastlake Ave East, Suite 208, SEATTLE, WA, 98102
- Phone: 316-210-7770
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| William Canestaro | Director | Seattle, WA |
| Sheila Gujrathi | Director | Boston, MA |
| John Kraft, II | Director | Seattle, WA |
| Anindya Roy | Director | Seattle, WA |
| John Kraft, II | Executive Officer | Seattle, WA |
| Anindya Roy | Executive Officer | Seattle, WA |
More